PSA
58
2
F
58
11
CSX
60
3
LYB
39
2
SEE
56
6
HAS
33
3
VZ
50
3
CPB
30
6
ADT
53
3
VNO
60
10
WDC
47
4
ADBE
49
3
WFC
79
4
BBY
46
10
EL
25
4
NVDA
56
-4
WAT
55
2
TSCO
49
5
DRI
53
5
INTC
33
-2
PSA
58
2
F
58
11
CSX
60
3
LYB
39
2
SEE
56
6
HAS
33
3
VZ
50
3
CPB
30
6
ADT
53
3
VNO
60
10
WDC
47
4
ADBE
49
3
WFC
79
4
BBY
46
10
EL
25
4
NVDA
56
-4
WAT
55
2
TSCO
49
5
DRI
53
5
INTC
33
-2
Financhill
Back

NeuroBo Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
22

NRBO
NeuroBo Pharmaceuticals

Last Price:
2.40
Seasonality Move:
6.18%

7 Day Trial

ALL ACCESS PASS

$ 7

Trade on Tuesday. Profit on Friday. Rinse & Repeat

Get the full details now.

NeuroBo Pharmaceuticals Price Quote

$2.40
+0.03 (+2.13%)
(Updated: November 23, 2024 at 5:47 AM ET)

NeuroBo Pharmaceuticals Key Stats

Sell
22
NeuroBo Pharmaceuticals (NRBO) is a Sell
Day range:
$2.35 - $2.45
52-week range:
$2.08 - $6.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.58%
Volume:
26.2K
Avg. volume:
36.3K
1-year change:
-30.57%
Market cap:
$20.4M
Revenue:
$0
EPS:
$-4.77

How Much Does NeuroBo Pharmaceuticals Make?

Data Unavailable

Is NeuroBo Pharmaceuticals Growing As A Company?

Data Unavailable

NeuroBo Pharmaceuticals Stock Price Performance

What Is NeuroBo Pharmaceuticals 52-Week High & Low?

NeuroBo Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy NeuroBo Pharmaceuticals?

Is NeuroBo Pharmaceuticals Cash Flow Positive?

  • What Is NRBO Cash Flow From Operations?
    Cash flow from operations (TTM) is -$22.7M
  • What Is NeuroBo Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $18.5M
  • What Is NeuroBo Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$17K

NeuroBo Pharmaceuticals Return On Invested Capital

Data Unavailable

NeuroBo Pharmaceuticals Earnings Date & Stock Price

NeuroBo Pharmaceuticals Competitors

NeuroBo Pharmaceuticals Dividend Yield

NeuroBo Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 26.67
Upside from Last Price: 1025.18%

Major Shareholders

  • How many NRBO shares are owned by institutional investors?
    12.9M NRBO shares are owned by institutional investors
  • How many NRBO shares are owned by insiders?
    4M NRBO shares are owned by insiders